Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1986 Jan;83(1):9-13.
doi: 10.1073/pnas.83.1.9.

Development of a chemically defined serum- and protein-free medium for growth of human peripheral lymphocytes

Comparative Study

Development of a chemically defined serum- and protein-free medium for growth of human peripheral lymphocytes

W Shive et al. Proc Natl Acad Sci U S A. 1986 Jan.

Abstract

A chemically defined, protein-free medium (designated CFBI 1000, where CFBI = Clayton Foundation Biochemical Institute) that supports human peripheral lymphocyte proliferation has been developed. This medium allows exploration of individual metabolic differences by varying the medium composition as well as providing a base to explore further the mechanisms of lymphocyte activation in a system initially free of added macromolecular species other than mitogen. The peripheral blood lymphocyte is an ideal system for metabolic studies because it is easily obtained, is a primary resting cell that can be activated to proliferate, and presumably reflects both the genetic makeup and biochemical environmental history of the individual at the time the cells were formed. Examination of the role of various factors in lymphocyte activation and subsequent events may be simplified by the utilization of a medium that is protein-free and chemically defined. The CFBI 1000 medium supports the growth response of human peripheral lymphocytes to mitogen as measured by [3H]thymidine incorporation to an extent comparable to other media used widely in assessment of lymphocyte proliferation.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Scand J Clin Lab Invest Suppl. 1968;97:77-89 - PubMed
    1. Proc Natl Acad Sci U S A. 1976 Jun;73(6):2023-7 - PubMed
    1. Clin Exp Immunol. 1976 Jul;25(1):28-35 - PubMed
    1. J Immunol. 1978 Mar;120(3):955-62 - PubMed
    1. Br J Haematol. 1978 Feb;38(2):219-33 - PubMed

Publication types

LinkOut - more resources